Extending Healthy Human Lifespan For All

Our mission is to promote biomedical technologies that will increase healthy human lifespan. By crowdfunding research efforts and engaging the public, we aim to more quickly bring about a future free from age-related diseases.

We are a US-based 501(c)(3) nonprofit organization headquartered in New York City, and we rely upon an international team of journalists, content creators, and other industry experts who are focused on supporting aging research, particularly the field of rejuvenation biotechnology, or geroscience. Our goal is to help build and support an industry that will end age-related diseases.

  • To date, we have raised over $390,000 for medical research focused on ending age-related diseases via our unique crowdfunding platform Lifespan.io, the first crowdfunding platform focused solely on aging research.
  • We report on the major industry events and breaking news, discussing the latest scientific advances in plain language in order to engage the public.
  • We interview the leading figures in aging research to bring you a unique insight into the cutting edge of medical science.
  • We produce science shows and researcher webinars to discuss aging research and introduce new audiences to the topic.
  • Our current outreach initiatives include Ending Age-Related Diseases, our annual conference series in New York City; journalist schools; speaking engagements at conferences and events; improving global policies on aging; and general advocacy for the field.
  • We work with popular YouTube channels and other influencers to produce films in support of aging research.


The global population is rapidly aging as fertility declines and life expectancy increases. According to the United Nations Population Prospects, in 2015, 12% of the global population were age 60 or over, and by 2050, 22% of the global population is projected to be age 60 or over. This is anticipated to grow in the following decades, and by 2100, old people will constitute about one-third of the global population.

With an increasingly older population comes an increased incidence of age-related disease and ill health. The increasing burden of age-related diseases places an unbearable load on healthcare systems. This creates a growing imbalance between the working population and people who can no longer work due to age-related disabilities, thus representing a major challenge for the global economy.

Health is the most important aspect of remaining productive and contributing to socioeconomic development. We believe that by supporting the creation and implementation of new biotechnologies aimed at bringing the aging processes under medical control, we could potentially help millions of people remain healthier for longer and have happier and more productive lives.


In 2015, inspired by the rising popularity of crowdfunding platforms such as Kickstarter and Indiegogo, we created our unique research crowdfunding platform Lifespan.io, which supports projects that are focused on the aging processes in order to delay, prevent, or cure age-related diseases.

A number of our fundraising projects have already started to bear fruit, such as the AgeMeter biomarker system, which is available now, and the MouseAge visual biomarker system, which is available free via the Apple Store. We will continue to support cutting-edge research projects that may not receive traditional grants, so check Lifespan.io often to see what new project launches are coming up and how you can get involved.


One large part of our mission is to offer the public information about the processes of aging and the progress in preventing and postponing age-related diseases through emerging medical technologies.

The LEAF team organizes educational events, takes part in different public and scientific conferences, and actively engages with the public on social media in order to help disseminate this crucial information. We initiate public dialogue aimed at improving regulations related to rejuvenation biotechnology.

We have also been featured in the media, appearing on national television, magazines, and newspapers, and we also travel the world speaking at scientific conferences and public events.

We also work to attract more attention from decision-makers to the need for increased funding allocation for fundamental and translational science.

We have achieved a great deal in our relatively short existence, and you can read more about what we have been up to in our achievements section.